Literature DB >> 27222887

Homozygous GNAL mutation associated with familial childhood-onset generalized dystonia.

Ikuo Masuho1, Mingyan Fang1, Chunyu Geng1, Jianguo Zhang1, Hui Jiang1, Riza Köksal Özgul1, Didem Yücel Yılmaz1, Dilek Yalnızoğlu1, Deniz Yüksel1, Anna Yarrow1, Angela Myers1, Sabrina C Burn1, Patricia L Crotwell1, Sergio Padilla-Lopez1, Ali Dursun1, Kirill A Martemyanov1, Michael C Kruer1.   

Abstract

Entities:  

Year:  2016        PMID: 27222887      PMCID: PMC4866576          DOI: 10.1212/NXG.0000000000000078

Source DB:  PubMed          Journal:  Neurol Genet        ISSN: 2376-7839


× No keyword cloud information.
Heterozygous loss-of-function mutations in the GNAL gene encoding the α subunit of the heterotrimeric G protein Golf (Gαolf) are known to cause isolated dystonia.[1,2] Gαolf is enriched in the striatum where it couples D1 dopamine (D1R) and A2A adenosine (A2AR) receptors to the activation of adenylyl cyclase type 5 (AC5). Mutations in ADCY5, the gene encoding AC5, are also known to lead to chorea and dystonia.[3,4] Previous functional studies of mutated Gαolf variants have revealed deficiencies in activation after D1R stimulation.[1,5] Patients with heterozygous GNAL mutations typically exhibit an adult-onset focal cervical, laryngeal, and/or segmental dystonia.[2] Such cases are typically either familial autosomal dominant or sporadic, resulting from de novo mutations. We describe a multiplex consanguineous Turkish family in which 2 affected children exhibited childhood-onset generalized dystonia. Affected patients were found to harbor a homozygous missense mutation in GNAL, representing biallelic mutations rather than the heterozygous GNAL mutations typically encountered. We enrolled the patients in our ethics and institutional review board–approved research study after obtaining written informed consent. The index patient was born at term without complications. The mother took no medications during her pregnancy. Growth and early milestones were attained on time. The girl's parents first became concerned at age 1 year when she began to show evidence of exaggerated muscle tone. As the girl grew older, generalized dystonia affecting the head/neck, trunk, and limbs emerged. She experienced academic difficulties upon starting school, and was diagnosed with mild intellectual disability. At age 15 years, she exhibited generalized dystonia and impaired volitional movement. She experienced action-induced spasms and exacerbations of her baseline dystonia. Laboratory workup was unrevealing and her neuroimaging was unremarkable. The girl's younger sister was also born at term without complications or prenatal exposures. She too met early motor and language milestones within the first year, but was noted to have hypertonia at age 1 year. She also lagged behind her peers in school and was diagnosed with mild intellectual disability. At age 11 years, she showed generalized dystonia that interfered with purposeful movements, with distressing dystonic spasms. Laboratory evaluations were nondiagnostic, and MRI of the brain was normal for age. Given the family structure, we suspected an autosomal recessive disorder with identity by descent. Because autosomal recessive dystonia mutations have only recently been described,[6] we began our studies suspecting a novel gene. We applied an approach of tandem homozygosity mapping and whole exome sequencing. We identified 5 blocks of homozygosity ≥3 Mb shared by the affected sisters but absent from unaffected siblings. Whole exome sequencing was performed using the Complete Genomics platform (appendix e-1 at Neurology.org/ng), and revealed a novel homozygous c.1216C>T (p.R329W) missense variant in GNAL (NM_182978) within a prominent block of homozygosity on chromosome 18 (hg19; chr18:7,490,028-15,143,714). This variant was predicted to be deleterious across several algorithms (SIFT, PolyPhen-2, MutationTaster, and PhyloP) and affects a residue that is highly conserved across species. This variant was not observed in the Exome Variant Server and ExAc Browser databases, and segregated in a homozygous form with affected status in the family (figure, A). Both parents and several siblings were heterozygous but did not display any overt dystonia.
Figure

GNAL mutation and functional characterization

(A) Family pedigrees. Filled symbols correspond to affected individuals. Empty symbols represent healthy individuals. Electropherograms show the missense mutation that leads to the (p.R293W) variant of GNAL. (B). Schematic of Gαolf functional coupling to D1R and bioluminescence resonance energy transfer (BRET) assay. Stimulation of the D1R by dopamine results in the dissociation of Gαolf from the heterotrimer. Released Gβγ subunits tagged with Venus become available for interaction with Nluc-tagged GRK reporter producing the BRET signal, which is determined by the change in the emission ratio at wavelengths 535 and 480 nm. (C) Time course. BRET signal changes upon stimulation of cells with dopamine and subsequent deactivation by haloperidol. (D) BRET ratios. Basal ratios calculated before the application of dopamine reflect the extent of the Gαolf–Gβγ heterotrimer formation, and changes in the BRET ratio from basal signal to maximal response reflect the amplitude of the response. Results represent the mean of quadruplicate wells from a typical experiment. Similar results were seen in 2 independent experiments. Error bars represent the SEM. An unpaired t test was performed to determine statistically significant differences. Asterisks indicate statistical significance from wild-type control: ***p < 0.001.

GNAL mutation and functional characterization

(A) Family pedigrees. Filled symbols correspond to affected individuals. Empty symbols represent healthy individuals. Electropherograms show the missense mutation that leads to the (p.R293W) variant of GNAL. (B). Schematic of Gαolf functional coupling to D1R and bioluminescence resonance energy transfer (BRET) assay. Stimulation of the D1R by dopamine results in the dissociation of Gαolf from the heterotrimer. Released Gβγ subunits tagged with Venus become available for interaction with Nluc-tagged GRK reporter producing the BRET signal, which is determined by the change in the emission ratio at wavelengths 535 and 480 nm. (C) Time course. BRET signal changes upon stimulation of cells with dopamine and subsequent deactivation by haloperidol. (D) BRET ratios. Basal ratios calculated before the application of dopamine reflect the extent of the Gαolf–Gβγ heterotrimer formation, and changes in the BRET ratio from basal signal to maximal response reflect the amplitude of the response. Results represent the mean of quadruplicate wells from a typical experiment. Similar results were seen in 2 independent experiments. Error bars represent the SEM. An unpaired t test was performed to determine statistically significant differences. Asterisks indicate statistical significance from wild-type control: ***p < 0.001. We suspected this missense change to be the probable cause of the patients' phenotype. To test this idea, we evaluated the ability of mutated Gαolf to be activated by the D1R upon reconstitution in HEK293T cells using our previously published bioluminescence resonance energy transfer (BRET) strategy[1] (figure, B). In mutants, the basal BRET ratio is elevated, indicating a marked deficit in Gβγ binding and/or protein stability (figure, C). We further observed a markedly diminished activation of mutated Gαolf in response to D1R stimulation with dopamine (figure, D), indicating an additional partial loss of function. Taken together, these findings suggest that our cases represent bona fide autosomal recessive GNAL-associated disease. The mutation seen in our patients seems to lead primarily to impaired Gαolf functional coupling to dopamine D1 receptors, differing from previously described mutations in GNAL that lead to a strict loss-of-function phenotype.[1,5] It is likely that, although the coupling of Gαolf with dopamine D1 receptors is impaired, enough normal protein is present in heterozygotes to retain the ability to bind the receptor efficiently and maintain adequate biological activity. Thus, only biallelic (p.R329W) mutations impair Gαolf functional coupling enough to cause the observed phenotype. Our findings indicate that mutations in GNAL may manifest through either autosomal dominant or recessive modes of inheritance, with the present patients exhibiting generalized dystonia with onset in childhood.
  6 in total

1.  A de novo ADCY5 mutation causes early-onset autosomal dominant chorea and dystonia.

Authors:  Raphael Carapito; Nicodème Paul; Meiggie Untrau; Marion Le Gentil; Louise Ott; Ghada Alsaleh; Pierre Jochem; Mirjana Radosavljevic; Cédric Le Caignec; Albert David; Philippe Damier; Bertrand Isidor; Seiamak Bahram
Journal:  Mov Disord       Date:  2014-12-27       Impact factor: 10.338

2.  Role of Gα(olf) in familial and sporadic adult-onset primary dystonia.

Authors:  Satya R Vemula; Andreas Puschmann; Jianfeng Xiao; Yu Zhao; Monika Rudzińska; Karen P Frei; Daniel D Truong; Zbigniew K Wszolek; Mark S LeDoux
Journal:  Hum Mol Genet       Date:  2013-02-27       Impact factor: 6.150

3.  Mutations in GNAL: a novel cause of craniocervical dystonia.

Authors:  Kishore R Kumar; Katja Lohmann; Ikuo Masuho; Ryosuke Miyamoto; Andreas Ferbert; Thora Lohnau; Meike Kasten; Johann Hagenah; Norbert Brüggemann; Julia Graf; Alexander Münchau; Vladimir S Kostic; Carolyn M Sue; Aloysius R Domingo; Raymond L Rosales; Lilian V Lee; Karen Freimann; Ana Westenberger; Youhei Mukai; Toshitaka Kawarai; Ryuji Kaji; Christine Klein; Kirill A Martemyanov; Alexander Schmidt
Journal:  JAMA Neurol       Date:  2014-04       Impact factor: 18.302

4.  Autosomal dominant familial dyskinesia and facial myokymia: single exome sequencing identifies a mutation in adenylyl cyclase 5.

Authors:  Ying-Zhang Chen; Mark M Matsushita; Peggy Robertson; Mark Rieder; Santhosh Girirajan; Francesca Antonacci; Hillary Lipe; Evan E Eichler; Deborah A Nickerson; Thomas D Bird; Wendy H Raskind
Journal:  Arch Neurol       Date:  2012-05

5.  Recessive mutations in the α3 (VI) collagen gene COL6A3 cause early-onset isolated dystonia.

Authors:  Michael Zech; Daniel D Lam; Ludmila Francescatto; Barbara Schormair; Aaro V Salminen; Angela Jochim; Thomas Wieland; Peter Lichtner; Annette Peters; Christian Gieger; Hanns Lochmüller; Tim M Strom; Bernhard Haslinger; Nicholas Katsanis; Juliane Winkelmann
Journal:  Am J Hum Genet       Date:  2015-05-21       Impact factor: 11.025

6.  Mutations in GNAL cause primary torsion dystonia.

Authors:  Tania Fuchs; Rachel Saunders-Pullman; Ikuo Masuho; Marta San Luciano; Deborah Raymond; Stewart Factor; Anthony E Lang; Tsao-Wei Liang; Richard M Trosch; Sierra White; Edmond Ainehsazan; Denis Hervé; Nutan Sharma; Michelle E Ehrlich; Kirill A Martemyanov; Susan B Bressman; Laurie J Ozelius
Journal:  Nat Genet       Date:  2012-12-09       Impact factor: 38.330

  6 in total
  8 in total

1.  Teenage Onset Head Tremor Due to Novel Mutation in GNAL Gene.

Authors:  Antoinette O'Connor; Mary Buckley; Sean S O'Sullivan
Journal:  Mov Disord Clin Pract       Date:  2017-10-20

2.  Gnal haploinsufficiency causes genomic instability and increased sensitivity to haloperidol.

Authors:  Mohammad Moshahid Khan; Jianfeng Xiao; T J Hollingsworth; Damini Patel; Dana E Selley; Trevor L Ring; Mark S LeDoux
Journal:  Exp Neurol       Date:  2019-04-26       Impact factor: 5.330

3.  Spectrum of Movement Disorders in 18p Deletion Syndrome.

Authors:  David Crosiers; Bettina Blaumeiser; Gert Van Goethem
Journal:  Mov Disord Clin Pract       Date:  2018-12-06

4.  Functional abnormalities in the cerebello-thalamic pathways in a mouse model of DYT25 dystonia.

Authors:  Hind Baba Aïssa; Romain W Sala; Elena Laura Georgescu Margarint; Clément Léna; Daniela Popa; Jimena Laura Frontera; Andrés Pablo Varani; Fabien Menardy; Assunta Pelosi; Denis Hervé
Journal:  Elife       Date:  2022-06-14       Impact factor: 8.713

Review 5.  Isolated dystonia: clinical and genetic updates.

Authors:  Aloysius Domingo; Rachita Yadav; Laurie J Ozelius
Journal:  J Neural Transm (Vienna)       Date:  2020-11-27       Impact factor: 3.575

Review 6.  Postsynaptic movement disorders: clinical phenotypes, genotypes, and disease mechanisms.

Authors:  Lucia Abela; Manju A Kurian
Journal:  J Inherit Metab Dis       Date:  2018-06-13       Impact factor: 4.982

7.  Autosomal recessive inheritance of ADCY5-related generalized dystonia and myoclonus.

Authors:  Matthew J Barrett; Eli S Williams; Chelsea Chambers; Radhika Dhamija
Journal:  Neurol Genet       Date:  2017-09-25

8.  Molecular Deconvolution Platform to Establish Disease Mechanisms by Surveying GPCR Signaling.

Authors:  Ikuo Masuho; Sreenivas Chavali; Brian S Muntean; Nickolas K Skamangas; Kristina Simonyan; Dipak N Patil; Grant M Kramer; Laurie Ozelius; M Madan Babu; Kirill A Martemyanov
Journal:  Cell Rep       Date:  2018-07-17       Impact factor: 9.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.